Happy to share that I will be presenting in the @APVnews online seminar on Latest Advances in R&D for LNPs for RNA Drug Delivery, which will be held on January 29, 2026!
More details at the following link: https://t.co/aalYedfu0z
Congrats to the 4 recipients of Trainee Challenge Awards, awarded through a partnership with ASPET and @PhRMAfoundation, recognized for their work in rapidly emerging areas in drug discovery research. Their award-winning research is free to read and share: https://t.co/HlzyPj39wa
Happy to share our latest review, led by @kishore13_16 and published in @JPET_Journal, which focuses on half-life extension of peptide and protein therapeutics!
https://t.co/eSQSzuoPVR
Happy to share the latest review article from our group published in @Cancers_MDPI, which focuses on PK/PD modeling strategies for antibody-drug conjugates. https://t.co/nILwMx0Ft8
Applications to become a 2026 ASPET Editorial Fellow are now open! Those chosen for the program will have an opportunity to learn important elements of the editorial process. The deadline for applications is November 17. Learn more and apply: https://t.co/dDSe8OmqWl
Getting ready to travel to Aurora, CO to attend ACoP 2025! I'll be co-teaching a post-conference workshop with @lab_rao and @SharifSoleman on PBPK modeling to support drug development!
New publication in collaboration with @PennMedicine, @PennEngineers , and @AcuitasTx in @PNASNews ! Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo | PNAS https://t.co/l4M45kS7pn
We're incredibly grateful to the #NIH for supporting our research with a $3 million 4-year R01 grant to develop targeted probiotic yeast therapies for inflammatory bowel diseases.
@DPMP_UNC@UNCPharmacy
We are now accepting applications for our online Graduate Certificate in PK and Mechanistic Modeling, which launches in Fall 2025! Please reach out with any questions!
https://t.co/27uOtoojwj
In addition, our PY2 student Manali Patel was selected as the top PharmD student abstract and gave an oral presentation on her work on half-life extended anti-thrombotics!
Please reach out if you are interested in submitting a primary research article or minireview to this issue - especially if you have a trainee that would be interested in the Challenge Award! @JPET_Journal@ASPET
ASPET’s JPET and @PhRMAFoundation are partnering on a Challenge Award competition—a prize of $5,000—to the first author of up to five winning papers! Submit your papers on the #pharmacology of next generation therapeutics by July 1, 2025.
🔗Learn more: https://t.co/gOqOQKurbd
ASPET’s JPET and @PhRMAFoundation are partnering on a Challenge Award competition—a prize of $5,000—to the first author of up to five winning papers! Submit your papers on the #pharmacology of next generation therapeutics by July 1, 2025.
🔗Learn more: https://t.co/gOqOQKurbd
I'm happy to share our latest publication in @BioconjChem describing the use of RBCs as carriers to prolong the circulation time of Factor IX! https://t.co/Oa6VvgGsX9
ASPET’s JPET and @PhRMAFoundation are partnering on a Challenge Award competition—a prize of $5,000—to the first author of up to five winning papers! Submit your papers on the #pharmacology of next generation therapeutics by July 1, 2025.
🔗Learn more: https://t.co/gOqOQKurbd
Happy to share information about a special issue of @JPET_Journal that I am co-editing with @JulieNguyenLab entitled Pharmacology of Next Generation Therapeutics. We've partnered with @PhRMAfoundation, who is sponsoring a Trainee Challenge Award!
https://t.co/Sb5JjsCtls
ASPET’s Editorial Fellowship Program is accepting applications for its 2025 class. Fellows will learn important elements of the editorial process, including all aspects of the submission process, peer review, and editorial decisions. Apply by Dec 11: https://t.co/3iELI0oPEh.
ASPET’s Editorial Fellowship Program is accepting applications for its 2025 class. Fellows will learn important elements of the editorial process, including all aspects of the submission process, peer review, and editorial decisions. Apply by Dec 11: https://t.co/OHMYpjZKop.